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Deep brain stimulationCortex-basal ganglia circuits participate in motor timing and temporal perception, and are important for the dy-
namic conﬁguration of sensorimotor networks in response to exogenous demands. In Parkinson3s disease (PD)
patients, rhythmic auditory stimulation (RAS) induces motor performance beneﬁts. Hitherto, little is known
concerning contributions of the basal ganglia to sensory facilitation and cortical responses to RAS in PD. There-
fore, we conducted an EEG study in 12 PD patients before and after surgery for subthalamic nucleus deep brain
stimulation (STN-DBS) and in 12 age-matched controls. Here we investigated the effects of levodopa and STN-
DBS on resting-state EEG and on the cortical-response proﬁle to slow and fast RAS in a passive-listeningparadigm
focusing on beta-band oscillations, which are important for auditory–motor coupling. The beta-modulation pro-
ﬁle to RAS in healthy participants was characterized by local peaks preceding and following auditory stimuli. In
PD patients RAS failed to induce pre-stimulus beta increases. The absence of pre-stimulus beta-bandmodulation
may contribute to impaired rhythm perception in PD.Moreover, post-stimulus beta-band responseswere highly
abnormal during fast RAS in PD patients. Treatment with levodopa and STN-DBS reinstated a post-stimulus beta-
modulation proﬁle similar to controls, while STN-DBS reduced beta-band power in the resting-state. The
treatment-sensitivity of beta oscillations suggests that STN-DBS may speciﬁcally improve timekeeping functions
of cortical beta oscillations during fast auditory pacing.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Akinesia, the inability to initiate and execute movements, is a key
aspect of impaired motor performance in patients suffering from
Parkinson3s disease (PD). Once set in motion, kinetic function in PD is
abnormally slow and reduced in amplitude. Furthermore, dynamic
motor output of PD patients shows a disturbed temporal coordination,
resulting in a set of characteristic movement irregularities (Sacks,
1999). Gait and speech of PD patients are often hastened, rapid alternat-
ing movements are difﬁcult to perform, and motor synchronization tosiology and Pathophysiology,
tinistr. 52, Hamburg 20246,
752.
. This is an open access article undersensory stimuli is globally impaired. A candidate neuronal mechanism
involved in these dysregulations of motor rhythmicity in PD patients
may encompass pathological levels of oscillatory brain activity within
coupled subcortical and cortical networks (Brown, 2003; Nagasaki
et al., 1978).
A characteristic signature of ongoing neuronal activity in the
dopamine-depleted motor circuitries of PD patients is abnormal
coupling at beta frequencies (13–30 Hz). Beta activity is excessively
synchronized within and between functionally interconnected nodes
in the basal ganglia (BG), thalamus and cortex, eventually resulting in
impaired motor function (Hutchison et al., 2004; Kühn et al., 2006;
Little et al., 2012; Sharott et al., 2014). Both dopaminergic medication
and deep brain stimulation of the subthalamic nucleus (STN-DBS)
reduce beta-band coupling within and between structures of this
functional loop in PDpatients. At the same time, these neuromodulatorythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tional signiﬁcance of beta oscillations for information processing in the
motor domain (Engel and Fries, 2010; Jenkinson and Brown, 2011). Be-
yond the antikinetic effects of elevated beta-band activity in the resting
brain state, their dynamic modulation is impaired in PD as well (Doyle
et al., 2005). Impaired beta modulation may lead to deﬁcient dynamic
scaling and sequencing of complex sensorimotor processes such as
gait (Singh et al., 2013), speech (Hebb et al., 2012) and repetitivemove-
ments (Joundi et al., 2013).
External sensory stimuli can temporarily ameliorate some of the
motor disabilities of PD patients (Cunnington et al., 1995; Martin,
1967). As an example, rhythmic auditory stimulation (RAS) improves
dysrhythmic locomotion and is frequently used to treat gait
disturbances in advanced stages of PD (McIntosh et al., 1997). However,
sensory facilitation by RAS depends on the stimulation frequency —
with slower presentation rates being more effective than fast rhythms
(Enzensberger and Fischer, 1996). Hitherto, little is known concerning
the neural processing of RAS in PD patients. More speciﬁcally, BG-
cortex circuits play a critical role modulating beta-band activity during
synchronization tasks as timekeeper for movements (Bartolo et al.,
2014; Rao et al., 1997; Teki, 2014), but it remains unknown how STN-
DBS and dopaminergic medication inﬂuence the cortical response
proﬁle to RAS in the absence of overt movement.
As a ﬁrst step, we re-addressed the question whether treatment
with levodopa or STN-DBS induces signiﬁcant changes in ongoing EEG
activity focusing, in particular, on the beta-band. To this end, we ana-
lyzed the resting state EEG of patients with advanced PD before
(DOPA-OFF versus DOPA-ON) and after STN-DBS surgery (OFF-DBS ver-
sus ON-DBS). In order to examine the speciﬁc inﬂuence of BG circuit
modulation on rhythm-related auditory processing, we then explored
the neurophysiological signatures of RAS in a passive listening paradigm
with slow (≤2 Hz) and fast (≥4 Hz) stimulus presentation rates under
these four experimental conditions. Since beta-oscillatory signals reﬂect
timekeeping functions in healthy people (Fujioka et al., 2012), we hy-
pothesized that RASwould reveal an altered beta-band response proﬁle
in patients with PD.
2. Material and methods
All statistical values are given as mean± SD unless noted otherwise.
Auditory evoked potential analysis of this dataset has been reported
elsewhere (Gulberti et al., 2015).
2.1. Patients & control participants
The present investigation was conducted in agreement with the
Code of Ethics of the World Medical Association (Declaration of Helsin-
ki, 1967) and the local ethics committee approved the procedures. All
participants provided written informed consent. Twelve patients (7 fe-
male, 5 male, mean age: 61 ± 6 years) with a diagnosis of advanced id-
iopathic PD (mean disease duration: 14 ± 3 years, Hoehn & Yahr stage:
3 ± 1; Hoehn and Yahr, 1967) and twelve healthy control persons
matched in sex, age and education (8 female, 4 male, mean age: 65 ±
8 years) participated. All participants declared normal hearing and nor-
mal or corrected-to-normal vision. Patients underwent bilateral
microelectrode-guided implantation of DBS electrodes in the STN. Pre-
operatively, all PD patients showed a signiﬁcant improvement of the
motor-subscore (III) of the Uniﬁed Parkinson3s Disease Rating Scale
(Fahn et al., 1987) following intake of levodopa. The mean motor
score after overnight withdrawal of anti-parkinsonian medication was
32 ± 12, while after intake of levodopa it was reduced to 18 ± 9
(t(11)=−5.54; p = 0.0002; paired t-test). This was a mean symptom
improvement of 44%. Pre-operatively, the daily levodopa-equivalent
dose was 1132 ± 420 mg. During the period of post-operative record-
ings, it was reduced to 663±354mg (t(22)=2.96; p=0.0073; paired
t-test; conversion factors used for the calculation of levodopa equivalentdaily dose after Tomlinson et al., 2010). Importantly, all patients demon-
strated an adequate global intellectual capacity, when tested with the
Mini-Mental Status Exam (Folstein et al., 1975; mean score: 29 ± 1)
and the Mattis Dementia Rating Scale (Mattis, 1988; mean score:
143 ± 0.5). Furthermore, they fulﬁlled other inclusion criteria for STN-
DBS, such as no structural alterations on magnetic resonance imaging
(MRI), and no concomitant severe medical comorbidities. Further clini-
cal details are summarized in Table 1.
2.2. Surgical procedures
For all patients DBS electrodes (model 3389, Medtronic, Minneapolis,
MN, USA) and stimulators (Kinetra model 7428 in 7 patients and Activa
PC model 37,601 in 5 patients, Medtronic, Minneapolis, MN, USA) were
implanted at the Department of Neurosurgery at the University Medical
Center Hamburg-Eppendorf, Germany. In short, an MRI-compatible
Zamorano–Dujovny frame (Stryker Leibinger) was tightly secured with
pins on the patient3s head. Gadolinium-enhanced volumetric T1 MRI
and T2-weighted spin echo MRI sequences were ﬁrst acquired, and
were then fused with computerized tomography scans by means of
iPlan (Brainlab), a commercial treatment planning software. Through
this procedure, both commissures, the STN-nigra complex and blood ves-
sels could be delineatedwith high resolution. A reference line connecting
the anterior and posterior commissure (AC–PC line) was then deter-
mined. The intended target coordinates for the STN were 11.5–12.5 mm
from the midline, 1–2 mm behind the midcommissural point and
2 mm below the line connecting anterior and posterior commissure.
For the surgical implantation of the electrodes, burr holes of 8–10 mm
diameter were fashioned 1–3 cm anterior to the left and right coronal
suture. Further details concerning the surgical procedure are reported
in Hamel et al. (2003).
Successful placement of the implanted DBS electrodes in the region
of the STN was assessed by intra-operative microelectrode recordings,
by effective intra-operative macrostimulation, by stereotactic recon-
struction of electrode contacts on post-operative stereotactic CT scans
fused with pre-operative MRIs, and by a signiﬁcant improvement in
the post-operative UPDRS motor score in DOPA-OFF condition: ON-
DBS (20 ± 8) vs. OFF-DBS (40 ± 10; t(9) =−7.89; p b 0.0001; paired
t-test). Two patients were excluded from this paired t-test due to miss-
ing post-operative UPDRS scores. Post-operatively, none of the patients
showed signs of accidental stimulation of ﬁber tracks running in the
neighboring internal capsule or lemniscal radiation.
2.3. Protocol
The ﬁrst experimental sessions took place 6 ± 5 days before the
implantation of bilateral STN-DBS electrodes for treatment of PD, the
second experimental sessions 5 ± 2 months following DBS surgery. In
the pre-operative recording sessions, patients were assessed in
(i) DOPA-ONand (ii) DOPA-OFF conditions. These two pre-operative re-
cordings always took place on two subsequent days and the order in
which the two conditions were recorded was counterbalanced. PD pa-
tientswere tested after an overnight period ofwithdrawal frommedica-
tion (DOPA-OFF condition). It is of note that all post-operative
recordings also took place after overnight withdrawal of anti-
parkinsonian medication on two different days. Post-operatively, the
two experimental conditions were: (iii) ON-DBS, i.e., during bilateral
therapeutic STN-DBS with high-frequencies (130–240 Hz) and
(iv) OFF-DBS, i.e., with the DBS device switched off. For each subject,
stimulation contacts, amplitude and pulse duration were the same as
for therapeutic high-frequency stimulation (see Table 1). After
switching off the therapeutic high-frequencies DBS, a period of time
≥25minwas elapsed before starting the recordings in the OFF-DBS con-
dition. This period has previously been demonstrated to be long enough
to induce a signiﬁcant worsening of motor symptoms following
Table 1
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1 m, 66 11 3.5 2022 mg 28 14 130 Hz, 1−, 4.0 V, 60 µs
130 Hz, 5−, 2.8 V, 60 µs
1357 mg 28 13 N/A
2 m, 60 12 2 1049 mg 26 9 240 Hz, 1+, 2−, 3−, 4.9 V, 120 µs
240 Hz, 5+, 6−, 7−, 4.4 V, 120 µs
962 mg N/A N/A N/A
3 f, 57 12 2.5 1422 mg 20 9 130 Hz, 1−, 2−, 2.2 V, 60 µs
130 Hz, 5−, 6−, 2.2 V, 60 µs
582 mg N/A 2 1
4 f, 54 20 3 1241 mg 22 11 130 Hz, 1−, 2−, 3.0 V, 60 µs
130 Hz, 5−, 6−, 2.6 V, 60 µs
597 mg 26 23 17
5 f, 66 14 3 760 mg 48 27 130 Hz, 1−, 2−, 3.9 V, 60 µs
130 Hz, 6−, 7−, 3.6 V, 90 µs
938 mg 44 25 19
6 f, 69 12 3 806 mg 47 42 200 Hz, 1−, 2−, 3.2 V, 60 µs
200 Hz, 5−, 6−, 3.0 V, 60 µs
660 mg 38 24 16
7 m, 68 6 2 972 mg 32 18 210 Hz, 1−, 2−, 3.2 V, 60 µs
210 Hz, 5−, 6−, 3.2 V, 60 µs
549 mg 33 12 10
8 m, 56 20 3 1131 mg 57 17 130 Hz, 1−, 3.2 V, 60 µs
130 Hz, 9−, 3.5 V, 60 µs
635 mg 57 25 10
9 f, 68 13 4 1431 mg 26 16 130 Hz, 2−, 1.9 V, 60 µs
130 Hz, 10−, 1.9 V, 60 µs
497 mg 44 27 19
10 m, 57 15 3 1437 mg 23 18 130 Hz, 1−, 2−, 3.0V, 60 µs
130 Hz, 9−, 10−, 3.0V, 60 µs
943 mg 52 32 27
11 f, 59 11 3 397 mg 26 12 200 Hz, 2−, 2.0 V, 60 µs
200 Hz, 10−, 2.5 V, 60 µs
56 mg 41 22 15
12 f, 53 11 2 912 mg 31 17 130 Hz, 1−, 2−, 2.3 V, 60 µs
130 Hz, 9−, 10−, 2.5 V, 60 µs
180 mg 37 18 14
Column “H&Y”: Hoehn & Yahr stages. Columns “Pre-op medication”, “Post-op medication”: levodopa equivalent daily doses (LEDD). Column “ DBS parameters”: stimulation frequency
(Hz), active contacts, impulse amplitude (V), impulse width (µs) for left and right electrode, respectively. For the left electrode (ﬁrst row), contact 0 was the most ventral and contact
3 was the most dorsal. For the right electrode (second row), contact 4 (or 8 in case of Activa PC stimulator) was the most ventral and contact 7 (or 11 in case of Activa PC stimulator)
was the most dorsal.
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line with clinical observations in our patient group.
2.4. Experimental setup and stimuli
The EEG-recordings took place in a darkened, sound-attenuated
chamber. Participants were comfortably seated in front of a 21-inch
monitor at a viewing distance of 155 cm, and written instructions of
the task were presented. Participants were asked to ﬁxate at a white
cross (diameter: 3 cm) and to listen passively to the presented auditory
stimuli without moving. Stimuli consisted of rhythmic metronome-like
clicks presented at 11 different stimulation rates, from 1 to 6 Hz
rhythms in steps of 0.5 Hz. For each rhythm-block, a series of 75 clicks
were presented. The order of the blocks was pseudo-randomized across
sessions and participants. Blocks were separated by a silent pause of 6 s.
Single clicks with a duration of 13 ms each, were presented at 70 dB
(SPL) through two loudspeakers located in front of the participant3s
head (Bose companion 2, series II, Framingham, MA, USA). At the end
of the task, participants were asked to sit quietly and ﬁxate the white
cross in front of them for 1 min in order to record ongoing EEG. Tri-
axial accelerometers ﬁxed on both index ﬁngers (Freescale Semicon-
ductor, MMA7260QT) permitted both on-line monitoring and post-
hoc quantitation of resting tremor episodes during the recordings.
Participants3 awareness was constantly tracked throughout the experi-
mental session with the help of EEG and electrooculogram (EOG)
parameters and video/intercom surveillance.
2.5. EEG recordings
EEG activity was recorded referenced to the nose tip from 62 active
Ag/AgCl scalp electrodes mounted in an elastic cap with equidistant
montage (EASYCAP GmbH, Herrsching, Germany). The electrodes had
integrated impedance converters ﬁtted directly into the electrode in
order to minimize noise from the surrounding area as well as from
movement artifacts. This aspect was of particular importance for EEG
recordings in PD patients with resting tremor (see below). In order torecord EOGactivities, two electrodeswere placed below the eyes. Accel-
erometer signals were collected simultaneously with the EEG activity.
The data were bandpass-ﬁltered (0.016–250 Hz) and digitized
(sampling rate: 1000 Hz) using BrainAmp ampliﬁers (BrainProducts,
Munich, Germany). Signal analyses were performed using Matlab 7.10
(MathWorks, Natick, MA), and two freely available open source tool-
boxes, EEGLAB 6.03b (Delorme and Makeig, 2004) and FieldTrip
(Oostenveld et al., 2011). Statistical analysis of the EEG was restricted
to a central region of interest (ROI), comprising the electrodes with
the largest auditory responses. This ROI included the averaged signal
of the vertex electrode Cz and of six neighboring electrodes (see
Fig. 1A). The sensor-level analysis of EEG data in our study precludes
precise statements concerning the speciﬁc neural sources. However, it
is likely that neuronal activity from frontal cortical areas, supplementary
motor area and perhapsmore posteriorly locatedmotor areaswas pick-
ed up by sensors within the central ROI. Thus, the chosen ROI was stra-
tegically positioned to sample activity from cortical areas and neural
systems with particular relevance to interval timing, rhythm percep-
tion, and auditory–motor coordination (Fujioka et al., 2012; Grahn
and Brett, 2007; Harrington et al., 1998; Rao et al., 1997; Schaal et al.,
2004; Toma et al., 2002).
2.6. Artifact removal
A two-step procedurewas performed to remove artifacts (Schneider
et al., 2008). First, epochs containing non-stereotyped artifacts
(e.g., cable movement, swallowing) were removed. Compromised elec-
trode traces were replaced by interpolated data. After the reduction of
the number of components to 32 by principal component analysis,
extended infomax independent component analysis (ICA) was applied
using a weight change b10−6 as stop criterion. Independent compo-
nents representing artifacts (e.g., DBS artifacts, eye blinks, saccadic
activity, ECG artifacts) were removed from the EEG data by back
projecting all but these components. Low-pass ﬁltering (cut-off fre-
quencies at 100 and 48 Hz for time–frequency and power spectrum
analysis, respectively) strongly reduced DBS-related artifacts. Despite
Fig. 1. Effects of treatment on resting-state EEG in the central ROI. Analysis of absolute and relative power in controls and in patients for the four therapy conditions. Absolute and relative
power spectra were subdivided into ﬁve frequency bands (delta, 2–4 Hz; theta, 4–8 Hz; alpha, 8–13 Hz; beta, 13–30 Hz; gamma, 30–48 Hz). (A) Comparison of absolute power spectra.
Inset, location of the seven averaged electrodes of the central ROI used for analysis of power. (B) Topographies of absolute power for controls and patient groups. (C) Absolute power in the
ﬁve frequency bands. Inset, enlarged version of the distribution for absolute beta-band power. (D) Relative power in the ﬁve frequency bands. Error bars indicate SEM.
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frequency-range were still present in 5 patients. ICA components
representing stimulation artifacts were clearly discernible due to their
circumscribed scalp distribution involving few neighboring EEG-
electrodes positioned over one or both DBS-electrodes. Furthermore,
these artifacts were characterized by a highly regular and stereotypical
appearance throughout the whole recording time as well as by
unphysiologically sharp peaks in their activity power spectra. As a
ﬁnal step, outlier epoch-values were automatically detected and
rejected (threshold criterion: ±100 µV).
In the present study four patients showed resting tremor. To limit the
inﬂuence of tremor-related muscle artifacts, active EEG electrodes were
used and statistical analyses of EEG activitieswere conﬁned to the central
ROI. Additionally, epochs with extensive tremor artifacts were excluded
and ICA components representing tremor artifacts were removed from
the EEG data. Application of this procedure ensured that for each partici-
pant at least 90% of all recorded trials could be retained.
2.7. Power spectrum analysis
A power spectrum analysis (Fast Fourier Transform) of the resting-
state EEG was performed using EEGLAB. Raw data were ﬁrst low-pass
ﬁltered (48 Hz), downsampled to 500 Hz and then high-pass ﬁltered
(2Hz). A linear-phase FIRﬁlter design using least-squares errorminimi-
zation was applied. 60-point low-pass ﬁltering was performed and the
low-pass transition bandwidth was 7 Hz. For high-pass, a 750-point ﬁl-
tering was performed and the high-pass transition bandwidth was
0.3 Hz. This procedure minimized the contribution of movement arti-
facts, slow drifts (b2 Hz) and the largest part of the stimulation artifactsin the ON-DBS condition (≥130 Hz) as well as line noise (50 Hz) arti-
facts. Filtering and application of the above mentioned two-step proce-
dure ensured that at least 50 s of the resting-state EEG recordings could
be retained for each participant (mean: 56± 4 s).Mean absolute power
and mean relative power were computed. Relative power is not inﬂu-
enced by factors such as electrode impedance, skull thickness or skin
conductance. Therefore it is often preferred over absolute power repre-
sentations. However, the interpretation of variations in frequency bands
or group comparisons may be difﬁcult when relying exclusively at rela-
tive power values, since frequencies in relative power are not quantiﬁed
independently of each other (Pivik et al., 1993; Stoffers et al., 2007). To
facilitate the evaluation of precise contributions to changes in relative
power, we decided to present relative power measures in conjunction
with absolute power (Pivik et al., 1993). For the relative power spec-
trum, we divided every bin (n = 94) of the power spectrum by the
sum of the full band power (2–48 Hz). Average power was then com-
puted separately for the 5 main frequency bands: delta (2–4 Hz),
theta (4–8 Hz), alpha (8–13 Hz), beta (13–30 Hz) and gamma
(30–48 Hz). In the case of absolute power, average power values for
the 5 main frequency bands were computed.
To compare changes of resting-state power spectra under different
conditions and in different groups,weﬁrst performed transformations to-
wards the normal distribution for absolute and relative band power as
suggested by Gasser et al. (1982): log x for absolute power and log [x /
(1− x)] for relative power, where x represents the absolute and the rel-
ative band power, respectively.We then performed the statistical analysis
for the 5main frequency bands. To test the variance of the ﬁve frequency
bands in the different therapy conditions and groups, ANOVAs with re-
peated measures were performed in PASW statistics (PASW Statistics
440 A. Gulberti et al. / NeuroImage: Clinical 9 (2015) 436–449for Mac version 18.0, SPSS Inc., Chicago, IL, USA). For interaction effects
Greenhouse–Geisser corrected p-values are reported if sphericity was vi-
olated (Mauchly3s sphericity test). Degrees of freedom are reported un-
corrected. To test the effect of different treatments on the relative and
absolute power distribution in comparison to healthy controls, four sepa-
rate ANOVAs were performed for the four experimental conditions
(DOPA-ON, DOPA-OFF, ON-DBS and OFF-DBS) vs. controls. The repeated
measures factor Frequency-Bands had 5 levels (relative or absolute
power in the ﬁve different frequency bands). Each between-subjects fac-
tor had two levels (each of the four PD-patients conditions vs. controls).
To test the effect of different treatments on the relative and absolute
power distribution in comparison to each other, six repeated measures
ANOVAs were performed with the within-subject factors Frequency-
Bands and all combinations of experimental conditions. In case of a signif-
icant main effect for Group or for Treatment (i.e., levodopa, surgery and
DBS) or an interaction effect with Frequency-Bands, subsequent post-
hoc analyses with regard to single band differences between Groups or
Treatments were performed (two-sample t-test, pooled for comparisons
between patients and control groups or paired-sample t-test for compar-
isons between the patients conditions). Correction for multiple compari-
sons is a relevant general topic concerning the analysis of non-random
biological, clinical and physiological data, where real associations are to
be expected and a priori hypotheses are generally formulated
(Rothman, 2014). As stated in the introduction, we expect a reduction
of the pathologically increased beta-band activity of PDpatients following
levodopa and DBS treatments. Having generated a speciﬁc hypothesis
concerning the differences in resting-state EEG beta-band activity in PD
patients implies that post-hoc procedures (usually used for exploratory
studies, where no speciﬁc a priori hypotheses have been made), and the
associated adjustments for multiple comparisons, would not strictly be
necessary, as they are reducing type I errors at the expense of increasing
type II errors (Field, 2009; Perneger, 1998; Rothman, 2014). Nevertheless,
for both absolute and relative power, the alpha level of post-hoc analyses
was conservatively Bonferroni-corrected for the 5 frequency bands
(i.e., p b 0.01).
2.8. Time–frequency and inter-trial coherence analysis
For the analysis of spectral changes in oscillatory activity, continuous
raw data were ﬁrst low-pass ﬁltered (100 Hz), downsampled to 500 Hz
and then high-pass ﬁltered (2 Hz). A linear-phase FIR ﬁlter design using
least-squares error minimization was applied. 30-point low-pass ﬁlter-
ingwas performed and the low-pass transition bandwidthwas 1Hz. For
high-pass, a 750-point ﬁltering was performed and the high-pass tran-
sition bandwidth was 0.3 Hz. Artifact removal was carried out as de-
scribed above. Epochs were then extracted from the continuous data
starting 500 ms before click onset and lasting for 1000 ms after click
onset. Baseline correction was applied in the interval from −500 ms
to stimulus onset. Finally, outlier epoch-values were automatically de-
tected and rejected setting a threshold value of±100 µV. For each chan-
nel, time–frequency analysis was performed on frequencies from 3 to
100 Hz (step size 1 Hz) using a “Hanning” taper. Using a slidingwindow
approach the taper (length 100 ms) was moved from−0.3 to 0.7 s in
steps of 5 ms. A 100 ms time window results in a frequency resolution
that is best for frequencies above 10 Hz. Since we were most interested
in beta frequencies (13–30 Hz), the choice of the above-mentioned
taper settings offered a good temporal resolution for this frequency of
interest. Furthermore the relatively short time window of 100 ms
prevented temporal smearing in the lower frequencies, which was im-
portant with respect to the short ISIs of the paradigm.
For time–frequency analyses, Fourier transformationwas performed
on the single-trial level prior to averaging. The resulting total power
contains both signal components phase-locked and non-phase-locked
to the stimulus. Power was then baseline corrected for each frequency
to obtain the relative signal change: P(t,f)corrected = 100 × (P(t,f) – P(f)
baseline) / P(f)baseline. The mean value across the whole epoch served asbaseline. This procedure avoids the introduction of noise from the base-
line into the activation period. Furthermore, an inter-trial coherence
(ITC) analysis was performed by averaging the phase of the complex
spectral estimates across single trials (Makeig et al., 2004; Tallon-
Baudry et al., 1996). ITC is a univariate measure reﬂecting the phase-
locking for speciﬁc frequencies at a single channel over trials. Thus, it
differs from bivariate coherence measures which reﬂect phase-locking
between two separate channels (Bruns, 2004; Herrmann et al., 2005).
Values ranging from 0 to 1 indicate how the phases are distributed
with respect to stimulus onset: a value of zeromeans complete random-
ly distributed phases, while a value of 1 represents a perfect phase-
locking to the stimulus. Mean total power in the frequency range from
3 to 80 Hz was calculated and plotted for all experimental conditions
in PD patients and for the control group. Time courses of single band
power change were calculated and plotted as the mean across the fre-
quencies from 4 to 7.5 Hz (theta), 8–12 Hz (alpha), 13–30 Hz (beta)
and 31–80 Hz (gamma).
For statistical analysis in the frequency domain, we separated the
rhythm conditions into two main groups: (i) rhythmic auditory stimu-
lation presented at slow rates (1, 1.5 and 2 Hz, hereafter referred to as
“slow RAS”) and (ii) fast auditory pacing (4, 4.5 and 5 Hz, “fast RAS”).
This subdivision was suggested by clinical observations and reports in
the literature that RAS at 1–2 Hz is particularly helpful to alleviate
motor impairments, especially gait disturbances, observed in PD
(Enzensberger and Fischer, 1996; McIntosh et al., 1997). In contrast,
auditory–motor coupling is severely impaired in response to RAS with
frequencies N3 Hz (Freeman et al., 1993; Freund and Hefter, 1993;
Logigian et al., 1991; Nakamura et al., 1978). Several reports in healthy
participants converge on the existence of two distinct timing mecha-
nisms for discrete (b2 Hz) and continuous (N3 Hz) movements (Huys
et al., 2008; Kunesch et al., 1989; Szirmai, 2010; Toma et al., 2002). Fur-
thermore, the change from a transient to a steady-state cortical activity,
as indexed by the overlap of neuronal responses during fast auditory
pacing, starts at RAS above 2 Hz (Carver et al., 2002). To avoid overlap
between these two putatively distinct timingmechanisms, we excluded
auditory stimulation rates between 2.5 and 3.5 Hz. Moreover, the two
fastest auditory stimulation rates (5.5 and 6 Hz) were excluded from
further analysis to avoid excessive overlapping of power change reset-
tings due to the temporal proximity of auditory events and to guarantee
a balanced comparison of three slow vs. three fast RAS conditions, re-
spectively. Grouping three slow and three fast frequencies increased
the trial number for each condition from 75 to 225, thus increasing
the statistical power for the analyses. Moreover, this approach reduced
the number of tests between auditory stimulation conditions, minimiz-
ing the probability of type-I statistical errors. Note that the epochs de-
ﬁned here (from −0.2 to 0.5 s relative to stimulus onset) are often
longer than the inter-stimulus intervals (ISI) and thus contain responses
tomore than one stimulus. This is particularly relevant for the “fast RAS”
group containing auditory pacing frequencies up to 5Hz (i.e., with an ISI
interval of 200 ms). Two adjacent peri-stimulus time-windows were
considered for non-parametric cluster-based statistical analysis. A pre-
stimulus time-window ranging from −80 to 0 ms (stimulus onset),
and a post-stimulus time-window from 0 ms (stimulus onset) to
80 ms were tested separately for pre- and post-stimulus intervals. To-
gether, both intervals had a length of 160 ms, which is shorter than
the ISI of the fastest RAS condition considered (i.e., 5 Hz, 200 ms ISI).
Cluster-based non-parametric randomization tests were performed
for mean values of power and ITC between groups (Controls vs.
DOPA-OFF and Controls vs. ON-DBS) and between conditions (DOPA-
ON vs. DOPA-OFF and ON-DBS vs. DOPA-OFF). These tests control the
type I error rate in experimental designs involving multiple compari-
sons by clustering adjacent time–frequency points exhibiting the same
effect (cluster α= 0.05, 1000 randomizations; Maris and Oostenveld,
2007). Results of power differences between groups and conditions
were plotted as z-scores and signiﬁcant clusters with p-values b 0.05
were highlighted. Differences in the beta-band power and ITC as a
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tions) were tested performing cluster-based non-parametric analyses
of the sampling points of the curves as described above. We appliedTable 2
Repeated measures ANOVA for effects of treatment and group on resting-state EEG.
Repeated measures ANOVA Factors Interaction of
df f p df f
Relative power
DOPA-OFF vs. DOPA-ON
Frequency-Bands 4,44 3.787 .048 4,44 3
Levodopa 1,11 4.374 .060
DOPA-OFF vs. OFF-DBS
Frequency-Bands 4,44 6.547 .005 4,44 8
Surgery 1,11 .297 .597
DOPA-OFF vs. ON-DBS
Frequency-Bands 4,44 3.831 .039 4,44 13
Surgery 1,11 .086 .775
DOPA-OFF vs. controls
Frequency-Bands 4,88 9.217 b.001 4,88 1
Group 1,22 7.139 .014
DOPA-ON vs. OFF-DBS
Frequency-Bands 4,44 9.435 .001 4,44 3
Surgery 1,11 3.511 .088
DOPA-ON vs. ON-DBS
Frequency-Bands 4,44 5.345 .013 4,44 2
Surgery 1,11 3.543 .087
DOPA-ON vs. controls
Frequency-Bands 4,88 12.319 b.001 4,88
Group 1,22 4.454 .046
OFF-DBS vs. ON−DBS
Frequency-Bands 4,44 9.527 b.001 4,44
DBS 1,11 .348 .567
OFF-DBS vs. controls
Frequency-Bands 4,88 22.819 b.001 4,88 3
Group 1,22 8.709 .007
ON-DBS vs. controls
Frequency-Bands 4,88 12.574 b.001 4,88 1
Group 1,22 6.414 .019
Absolute power
DOPA-OFF vs. DOPA-ON
Frequency-Bands 4,44 29.383 b.001 4,44 3
Levodopa 1,11 .600 .455
DOPA-OFF vs. OFF-DBS
Frequency-Bands 4,44 43.843 b.001 4,44 8
Surgery 1,11 .584 .461
DOPA-OFF vs. ON-DBS
Frequency-Bands 4,44 30.879 b.001 4,44 14
Surgery 1,11 2.391 .150
DOPA-OFF vs. controls
Frequency-Bands 4,88 71.830 b.001 4,88 1
Group 1,22 18.627 b.001
DOPA-ON vs. OFF-DBS
Frequency-Bands 4,44 70.890 b.001 4,44 3
Surgery 1,11 .045 .836
DOPA-ON vs. ON-DBS
Frequency-Bands 4,44 49.447 b.001 4,44 2
Surgery 1,11 11.963 .005
DOPA-ON vs. controls
Frequency-Bands 4,88 122.296 b.001 4,88
Group 1,22 24.134 b.001
OFF-DBS vs. ON-DBS
Frequency-Bands 4,44 64.007 b.001 4,44 1
DBS 1,11 4.339 .061
OFF-DBS vs. controls
Frequency-Bands 4,88 176.203 b.001 4,88 3
Group 1,22 20.167 b.001
ON-DBS vs. controls
Frequency-Bands 4,88 120.963 b.001 4,88 1
Group 1,22 9.359 .006
The reported values are degrees of freedom(df), F- andp-values for all the performed repeatedm
are Frequency-Bands (delta, theta, alpha, beta, gamma) and Treatment (Levodopa, Surgery, DBS
sures ANOVAwith p values still signiﬁcant after Bonferroni corrections for the 20 separate ANOV
≤0.06 are reported in underlined font. If signiﬁcant effects of factor Treatment or signiﬁcant inte
post-hoc p-values for t-test comparisons between single frequency bands are reported. For p
(i.e., p b 0.01).two-sample t-tests, pooled for comparisons between patients and con-
trol groups and paired-sample t-tests for comparisons between the dif-
ferent experimental conditions in patients, respectively.factors p-values of post-hoc analyses for:
p Delta Theta Alpha Beta Gamma
.416 .050 .006 .044
.779 .003 b.001 .027 .017
.115 b.001 .008 b.001 .002 .006
.178 .317 .015
.845 .034 .018
.625 .047 .041 .015
.180 .842
.979 .404
.335 .014 .037 .049
.640 .195 .034
.423 .053 .016
.625 .005 .013 .003 .037
.752 b.001 .008 .008
.122 .335 .050 .030 .002 .006 .003
.535 .049 .038
.492 .105 .002 .020
.192 .837 b.001 .001 b.001 .010 .005
.108 .350 .039 .025
.035 .021 .002 b.001 b.001 .021 .018
.423 .249 .026 0.009 .022 .044
easures ANOVA for both relative and absolute power changes. Thewithin-subjects factors
). The between-subjects factor is Group (patients vs. controls). Results of the repeatedmea-
As are highlighted in bold (i.e., p b 0.0025), while resultswith p-values between≥0.05 and
ractions between factor Treatment and factor Frequency-Bandswere found in the ANOVA,
ost-hoc tests, p-values still signiﬁcant after Bonferroni corrections are reported in bold
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3.1. Effects of levodopa and STN-DBS on resting-state EEG
To test whether cortical activity was inﬂuenced by experimental
conditions in the absence of sensory stimulation, we ﬁrst investigat-
ed possible effects of levodopa and STN-DBS on absolute and relative
spectral power of the resting-state EEG (Fig. 1). We focused on spec-
tral power recorded in the central ROI, since this region showed the
most pronounced EEG-activity modulation in response to the RAS.
Speciﬁcally, we intended to characterize beta-band resting-state
power changes in this ROI in regard to the different treatments. To
this end, we performed repeated-measures ANOVA with between-
subjects factor Group (patients vs. controls) and within-subjects
factors Frequency-Bands (delta, theta, alpha, beta, gamma) and
Treatment (DOPA-OFF, DOPA-ON, OFF-DBS, ON-DBS). Table 2 sum-
marizes the results of the ANOVA analysis for both relative and abso-
lute power. Relative power measures are displayed in conjunction
with absolute power to ensure an accurate evaluation of contribu-
tions to changes in relative power (Pivik et al., 1993). Adjusting sta-
tistical signiﬁcance for the number of tests that have been performed
is recommended to control for type I errors (i.e., detecting an effect
that is not present). Unfortunately, this procedure is often inﬂating
type II errors (i.e., truly important differences are deemed non-
signiﬁcant) and thus missing real differences (Perneger, 1998;
Rothman, 2014, 1990). Therefore, we report here the uncorrected re-
sults, as suggested by a number of statisticians (Bender and Lange,
2001; Perneger, 1998; Rothman, 2014, 1990; Saville, 1990; Savitz
and Olshan, 1995). Highlighted are p-values, which would survive
most conservative Bonferroni corrections (i.e., p-values b 0.0025Fig. 2.Mean total power and power time courses. (A–E) Effects of slow RAS on total power in co
plots of the total power averaged across rhythmic auditory stimulation at 1, 1.5 and 2 Hz. Two p
ulus power increase involving in particular beta frequencies (13–30Hz,−70–0ms); (II) an early
courses for the theta-, alpha-, beta- and gamma-band. (F–J) Effects of fast RAS on total power. To
stimulation at 4, 4.5 and5Hz. Boxes in (F) indicate the same two response components as in (A)
auditory pacing frequencies up to 5 Hz, i.e., with an inter-stimulus interval (ISI) of 200 ms. No
contain responses to more than one stimulus. All time–frequency plots and power time coursefor the 20 separate ANOVAs reported in Table 2 are marked in bold,
and p-values b 0.00625 for the 8 power changes comparisons report-
ed in Fig. 3 are marked with an asterisk). It should be noted that all
post-operative recordings took place after overnight withdrawal of
anti-parkinsonian medication.
3.1.1. Relative power changes
For relative power we consistently found main effects of
Frequency-Bands and Group (patients vs. controls, Fig. 1D and
Table 2). The interaction between Frequency-Bands and Group
reached signiﬁcance in the comparison OFF-DBS vs. controls. Signif-
icant interaction effects between Frequency-Bands and Treatment
were found in the comparison of the two pre-operative conditions
DOPA-OFF and DOPA-ON with the two post-operative conditions
OFF-DBS and ON-DBS. Compared to the pre-operative baseline mea-
surement in the absence of dopaminergic medication (DOPA-OFF), a
signiﬁcant increase of relative power in the theta frequency band
was observed for patients in both post-operative conditions (see
Fig. 1D). Notably, a signiﬁcant reduction of relative power in the
beta and gamma frequency range was observed for the post-hoc
comparison DOPA-OFF vs. ON-DBS, pointing to a DBS-induced reduc-
tion of cortical high-frequency power (see Fig. 1D).
In summary, after DBS surgery a shift of relative power from beta
and gamma frequencies towards theta was evident in the group of PD
patients.
3.1.2. Absolute power changes
In a similar vein, analysis of absolute power revealed main effects
of Frequency-Bands and Group (patients vs. controls), and a signiﬁ-
cant interaction of factors Frequency-Bands and Group for thentrols and in patients for the four therapeutic conditions. Top panels show time–frequency
eri-stimulus response components were identiﬁed inmean total power (A): (I) pre-stim-
power increase (4–80Hz, 0–120ms). Bottompanels showperi-stimulus total power time
p panels show time–frequency plots of the total power averaged across rhythmic auditory
. Bottompanels showperi-stimulus total power time courses. The “fast RAS” group contains
te that the epochs plotted here are longer than ISIs for the “fast RAS” condition and thus
s display signal change (in %) relative to the average across the entire data epoch.
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higher absolute power values than controls across all frequency
bands — except for beta-band activity in the comparison between
controls and patients ON-DBS (Fig. 1A, C and Table 2). Furthermore,
and in line with the results on relative power, signiﬁcant interactions
of factors Frequency-Bands and Treatment were found in the com-
parisons DOPA-OFF vs. OFF-DBS and ON-DBS, as well as DOPA-ON
vs. OFF-DBS. In line with the results on relative power, post-hoc
tests comparing absolute power between DOPA-OFF vs. OFF-DBS
showed a signiﬁcant increase in theta-band power for patients
OFF-DBS. When directly comparing DOPA-OFF to ON-DBS, absolute
beta and gamma power was signiﬁcantly reduced in the ON-DBS
condition. A similar reduction of absolute beta power with ON-DBS
was also found in the post-hoc comparisons with the DOPA-ON con-
dition. Notably, beta power in the ON-DBS condition was reduced
compared to the OFF-DBS condition in the post-hoc contrast be-
tween ON-DBS vs. OFF-DBS (p = 0.025; see inset of Fig. 1C). Howev-
er, this difference did not survive a conservative Bonferroni
correction (i.e., p b 0.01).
Taken together, after surgery an increment of theta power with DBS
switched OFF was observed in PD patients. Importantly, STN-DBS sup-
pressed high-frequency activities and lowered in particular beta-band
oscillatory power to control level.3.1.3. Reliability of resting-state power recordings
The topographical patterns of absolute power in the EEG were
similar for all frequency bands, irrespective of group or experimen-
tal condition (Fig. 1B). The ﬁnding of consistent scalp topographies
for resting-state activity before and after surgery — as well as in
comparison with the control group — argues against a signiﬁcant
impact of DBS-artifacts and/or component rejections in our study.
We cannot categorically exclude possible contributions from unde-
tected DBS-artifact activity, but believe that the results reported
here were not signiﬁcantly biased by our careful artifact-removal
procedure.
In order to investigate a possible inﬂuence of resting tremor on on-
going theta-band activity, we correlated absolute EEG theta power
with the corresponding tremor power values as derived from simulta-
neous accelerometry recordings. To this end, we performed a spectral
analysis (Fast Fourier Transform, same settings as for EEG analysis) for
the accelerometer signals. Average tremor power values between 4
and 8 Hz were then computed for the two conditions DOPA-OFF and
OFF-DBS, in the absence of anti-parkinsonian medication. Due to the
non-normal distribution of tremor and theta power values (Shapiro–
Wilk Test, alpha level = 0.05), p and rho values were calculated using
non-parametric Spearman3s correlations. Tremor power values did not
correlate with theta-band power in the EEG, neither in the pre-
operative condition DOPA-OFF (rho = −0.08; p = 0.82) nor in the
post-operative condition OFF-DBS (rho =−0.45; p = 0.14). A direct
comparison of tremor power between these two pre- and post-
operative conditions did not show signiﬁcant differences (W(11) =
25; 0.30; Wilcoxon signed rank test). To stay in line with the methods
applied before in other studies of resting-state EEG in Parkinson3s dis-
ease (Bosboom et al., 2006; Silberstein, 2005; Stoffers et al., 2007), we
correlated absolute theta power values also with the corresponding
tremor sub-scores in the motor subsection of the UPDRS (UPDRS part
III, sum of items 20 and 21) of conditions DOPA-OFF (mean score
3.8 ± 3.9) and OFF-DBS (mean score 5.1 ± 3.1). UPDRS tremor scores
did not correlate with theta-band power in the EEG, neither in the
DOPA-OFF (rho = 0.21; p = 0.51) nor in the OFF-DBS condition
(rho = 0.31; p = 0.38).
Consequently, it is improbable that tremor artifacts accounted for
the observed post-operative theta power increase in the EEG, in accor-
dance with previous results reported by Bosboom et al. (2006) and
Stoffers et al. (2007).3.2. Time–frequency analysis of event-related power changes and inter-
trial coherence
3.2.1. Evoked and induced oscillations
Oscillatory signals can be deﬁned by their amplitude and phase.
Evoked oscillations are phase-locked to the stimuli, i.e., they reﬂect
those components of the oscillatory signal whose phase is similar after
every stimulus presentation. Evoked power can be considered as the
frequency-domain equivalent of the event-related potential. In contrast,
induced neuronal oscillations are not phase-locked to stimulus onset.
We ﬁrst carried out a time–frequency analysis of event-related changes
in total power (Fig. 2), which comprises both induced and evoked
oscillatory components. In order to disentangle which parts of the
power responses are phase-locked to the stimuli, we analyzed inter-
trial coherence (ITC; Fig. 4).
In the following paragraphs and ﬁgures, time–frequency analysis re-
sults will be presented in succession, ﬁrst for slow and then for fast RAS.
3.2.2. Total power changes during slow RAS
During slow RAS, two distinct peri-stimulus components could be dif-
ferentiated in the EEG total power for healthy control participants (la-
beled I and II in Fig. 2A). (I) From −70 to 0 ms before stimulus onset,
low-frequency oscillations — mainly in the beta-band — displayed a
local peak. As illustrated by the line plot graphs in Fig. 2B–E, this pre-
stimulus beta-power modulation was absent in all conditions in PD
patients. (II) Immediately after stimulus onset, a phasic broad-band
(4–80 Hz) power increase was evident, rapidly decaying within the ﬁrst
120ms. The duration of this broad-band peakwas considerably increased
(for ~50 ms) in PD patients (Fig. 2B–E). Irrespective of levodopa treat-
ment, post-stimulus theta and alpha power was excessively high in pa-
tients before surgery (Fig. 2B and C) compared to post-operative
recordings (Fig. 2D and E) or healthy controls (Fig. 2A). Cluster-based sta-
tistic of event-related power changes revealed pre-stimulus differences—
mainly within the beta-band — for contrasts between patients in DOPA-
OFF and ON-DBS vs. controls (cluster randomization test, p = 0.016 and
p = 0.019, respectively; upper panels of Fig. 3A and D).
3.2.3. Time courses of beta-band total power during slow RAS
As oscillatory activity in the beta-band (13–30 Hz) has repeatedly
been postulated to play an important role in rhythm perception and
audio-motor integration, we thoroughly examined changes in this par-
ticular frequency band and visualized itsmodulation proﬁle as line plots
in bottom panels of Fig. 3A–D. The most salient power difference be-
tween patients and controls during slow RAS was consistently found
shortly before stimulus onset. This increase of beta oscillatory activity
preceding stimulus onset was absent in patients (Fig. 3A and D). In
the control group, auditory beta power modulation displayed a stereo-
typical triphasic proﬁle (see line plots in lower panels of Fig. 3A and
E). A pre-stimulus beta power increase (−70–0 ms), returning to base-
line levels around stimulus onset was followed by a post-stimulus beta
power increase (20–100 ms). While controls showed a clear beta peak
shortly (~40 ms) before stimulus onset during slow RAS (marked by
an arrowhead bottom panels of Fig. 3), this pre-stimulus beta modula-
tion was absent in patients in DOPA-OFF (cluster randomization test,
p = 0.005*) and ON-DBS (cluster randomization test, p = 0.015).
Note that the post-stimulus beta modulation proﬁle during slow RAS
was largely similar between the two groups. Moreover, the contrast
between the two post-operative conditions (ON versus OFF-DBS) was
statistically not signiﬁcant.
3.2.4. Inter-trial coherence (ITC) during slow RAS
Fig. 4 depicts the phase-locking across trials as reﬂected in ITC
values. According to this ITC analysis, only the second (post-stimulus)
component of the two previously described response components
contained phase-locked oscillatory activity (Fig. 4, upper panels A–E).
The early power increase (component II, 0–120 ms) was phase-locked
Fig. 3.Mean differences and time courses of beta-band total power. (A−H, top panels)Mean power differences at slow RAS (auditory stimulation at 1, 1.5 and 2Hz) and fast RAS (auditory
stimulation at 4, 4.5 and 5 Hz). Unmasked regions in the plots show signiﬁcantly different z-score clusters (A−H, bottom panels). Time courses of beta-band power at slow and fast RAS.
Arrowheads indicate the pre-stimulus beta power increase (−70–0ms) observed in controls. Gray shaded areas in the bottompanels show signiﬁcantly different beta-band changes. The
“fast RAS” group contains auditory pacing frequencies up to 5 Hz, i.e., with an inter-stimulus interval (ISI) interval of 200ms. Note that the epochs plotted here are longer than ISIs for the
“fast RAS” condition and thus contain responses to more than one stimulus. The peri-stimulus frames marked in the panels represent the time interval used for statistical testing of dif-
ferences of event-related power changes for the entire considered frequency range (3–80 Hz; upper panels) and for beta-power time courses (for details see methods section). Testing
was conﬁned to this time interval to avoid overlappingwith preceding or successive stimulus events. All time–frequency plots and power time courses display signal change (in %) relative
to the average across the entire data epoch.
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around 40 Hz. In contrast, component I — representing a pre-stimulus
increase of beta power (13–30 Hz, −70–0 ms) — was clearly not
phase-locked to the stimulus and may therefore reﬂect an intrinsically
generated oscillatory process. Cluster-based statistical analysis of
the two peri-stimulus components did not show any signiﬁcant
ITC-difference for the abovementioned contrasts, neither in the whole
frequency range (3–80Hz), nor in themore speciﬁc analysis of temporal
proﬁles of beta-band power (cluster randomization tests, p N 0.05; data
not shown).
3.2.5. Total power changes during fast RAS
At fast RAS, response modulations of the previously described total
power response components were still apparent but generally less dis-
tinct and of lower magnitude compared to responses during slow audi-
tory pacing (upper panels of Fig. 2F–J). Notably, a pre-stimulus beta
power increasewas still present in healthy control subjects (component
I in Fig. 2F), but this peak was never observed in PD patients. (II) Post-
stimulus amplitude modulation was still dominated by a broad-band
power increase in both patients and controls, albeit of shorter duration
and smaller magnitude compared to slow RAS. Similar to slow RAS,
periodic entrainment of theta-, alpha- and beta-power by fast RAS was
especially pronounced before DBS surgery (Fig. 2G and H). In the post-
operative conditions, the overall response modulation level was in the
same range as for healthy participants. In particular, the low-
frequency content of the dominant broad-band power increase (com-
ponent II) was much reduced during fast auditory pacing following
DBS surgery (Fig. 2I and J). Cluster-based statistics of event-related
power changes revealed a signiﬁcant pre-stimulus deﬁciency of powerpredominantly in the beta-band in PD patients in DOPA-OFFwhen com-
pared to controls (cluster randomization test, p = 0.006*; upper panel
of Fig. 3E). Post-stimulus differences in the beta-band were signiﬁcant
in the contrasts controls vs. DOPA-OFF (cluster randomization test,
p = 0.034; upper panel of Fig. 3E), DOPA-OFF vs. ON-DBS (cluster ran-
domization test, p = 0.013; upper panel of Fig. 3F) and DOPA-ON vs.
DOPA-OFF (cluster randomization test, p = 0.04; upper panel of
Fig. 3G).
3.2.6. Time courses of beta-band total power during fast RAS
The speciﬁc temporal dynamics of beta-band responses during fast
RAS also displayed signiﬁcant differences between patients and con-
trols. For patients OFF medication, the periodic beta power ﬂuctuations
after stimulus onset appeared to be shifted ahead in time when com-
pared to controls, DOPA-ON and ON-DBS (see line plots in Fig. 3E–G).
Furthermore, the duration of these stimulus-induced beta peaks were
signiﬁcantly longer in patients OFF medication (peak width at half
height, 106 ms) compared to controls (peak width, 46 ms; cluster ran-
domization test, p=0.027). A slight beta decrease, which characterized
the power ﬂuctuation immediately before stimulus onset in control
subjects, was replaced by gradual ramping of beta power across
stimulus onset in patients without levodopa (cluster randomization
test, p = 0.045). Interestingly, both dopaminergic medication and DBS
normalized the time course and peak duration of stimulus-driven beta
power ﬂuctuations in the fast RAS condition. This is illustrated by signif-
icant differences of beta power line plots for DOPA-ON compared to
DOPA-OFF (Fig. 3G; cluster randomization test, p = 0.001*) and ON-
DBS compared to DOPA-OFF (Fig. 3F; cluster randomization test, p =
0.003*). There was no longer a statistical difference between controls
Fig. 4. ITC spectral characteristics and time courses. (A–E) Effects of slowRASon ITC in controls and inpatients for the four therapy conditions. Toppanels show time–frequency plots of the
ITC computed across all trialswith auditory stimulation at 1, 1.5 and 2Hz. The boxes in the upper panels of (A) indicate the position of the two power-response components as described in
Fig. 2. Bottompanels show ITC courses for the theta-, alpha-, beta- and gamma-band. Note that only response component II shows phase-locking to the stimulus. (F–J) Effects of fast RAS on
ITC. Top panels show time–frequency plots of the ITC computed across all trials with auditory stimulation at 4, 4.5 and 5 Hz. Boxes in (F) indicate the same two response components as in
(A). Bottom panels show ITC time courses. The “fast RAS” group contains auditory pacing frequencies up to 5 Hz, i.e., with an inter-stimulus interval (ISI) of 200 ms. Note that the epochs
plotted here are longer than ISIs for the “fast RAS” condition and thus contain responses to more than one stimulus. This also explains the higher baseline offset for fast RAS (0.2) than for
slow RAS (0.1), since the mean ITC-value across the whole epoch served as baseline.
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tion, the pre-stimulus beta-band increase was still absent for patients
with DBS-ON (Fig. 3H). No statistical signiﬁcant difference was found
for the comparison between OFF- and ON-DBS in the processing of
fast RAS.
3.2.7. Inter-trial coherence (ITC) during fast RAS
ITC analysis revealed that, as for the slow RAS condition, the pre-
stimulus beta-modulation observed in control participants (component
I)was not phase-locked to the auditory stimuli in PD patients. As for the
slow RAS condition, cluster-based statistical analysis of the peri-
stimulus components did not show any signiﬁcant ITC-difference for
the considered contrasts, neither when examining the whole frequency
range (3–80 Hz), nor for the temporal proﬁles of beta power (cluster
randomization tests, p N 0.05; data not shown).
3.2.8. Interrelation between pre- and post-stimulus oscillatory activities
To test the interaction between pre- and post-stimulus beta-band
oscillatory activities in controls and in patients for the four therapeutic
conditions, correlations of pre- and post-event mean values of beta-
band activities were calculated. Mean beta power as well as mean ITC
values were computed for the two adjacent intervals considered for
the peri-stimulus statistical analysis (i.e., a pre-stimulus time-window
from −80 to 0 ms, and a post-stimulus time-window from 0 to
80 ms). Due to the non-normal distribution of beta power values (Sha-
piro–Wilk Test, alpha level = 0.05), p and rho values were calculated
using non-parametric Spearman3s correlations.
For slow RAS pre-stimulus beta power values did not correlate with
post-stimulus beta power values, neither in controls (rho=−0.07; p=
0.83), nor in the four therapeutic conditions DOPA-OFF (rho =−0.21;
p = 0.51), DOPA-ON (rho =−0.18; p = 0.57), OFF-DBS (rho = 0.02;
p = 0.96), ON-DBS (rho = 0.24; p = 0.44). Notably, for the fast RASinstead, signiﬁcant negative correlations were found in controls
(rho = −0.67; p = 0.020), in patients in DOPA-OFF (rho = −0.71;
p = 0.012) and in ON-DBS (rho = −0.70; p = 0.014). Patients in
DOPA-ON (rho =−0.50; p = 0.099) and in OFF-DBS (rho = −0.49;
p = 0.10) exhibited a negative correlation trend between pre- and
post-stimulus beta power that did not reach signiﬁcance.
As for beta-band power, at slow RAS pre-stimulus beta-band ITC
values did not correlate with post-stimulus beta-band ITC values, nei-
ther in controls (rho= 0.20; p= 0.53), nor in the four therapeutic con-
ditions DOPA-OFF (rho =−0.21; p = 0.51), DOPA-ON (rho =−0.34;
p = 0.29), OFF-DBS (rho =−0.37; p = 0.24), ON-DBS (rho =−0.10;
p = 0.77). Also at fast RAS, no signiﬁcant correlations between pre-
and post-stimulus beta-band ITC values were observed — neither in
controls (rho=−0.21; p=0.51), nor in the four therapeutic conditions
DOPA-OFF (rho= 0.14; p= 0.67), DOPA-ON (rho==0.09; p= 0.78),
OFF-DBS (rho=−0.37; p=0.24), and ON-DBS (rho=0.36; p=0.26).
From this correlation analysis we can exclude carry over effects be-
tween pre- and post-event beta-band activities due to the temporal res-
olution of time frequency analysis and the temporal proximity of events.
In such a case we would have expected signiﬁcant positive correlations
between pre- and post-stimulus beta activities, but this case was
never observed.
Importantly, both the ITC analysis and the absence of any correlation
between pre- and post-stimulus beta-band ITC values, suggest that the
pre-stimulus beta-modulation in control persons was not phase-
locked to the auditory stimuli, and thus the reported pre-stimulus dif-
ferences are due to changes in intrinsically generated beta-band power.
4. Discussion
In this study, we have investigated the effects of dopaminergic med-
ication and high-frequency STN-DBS on resting-state EEG-activity and
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on oscillatory activity in the beta frequency range. Here, we provide the
ﬁrst evidence for deﬁcient sensory processing of rhythmic auditory
stimuli in patients with PD that is both tempo-dependent and sensitive
to neuromodulatory treatment. First, chronic STN-DBS led to a reduc-
tion of cortical beta-band power in the resting-state, thus providing fur-
ther support for a speciﬁc inﬂuence of STN-DBS on cortical beta activity.
Second, in response to RAS beta-band power was consistently peaking
shortly before stimulus onset in healthy subjects, which was never ob-
served in PD patients. In the patients group the post-stimulus beta am-
plitude modulation was also highly abnormal. We could demonstrate
that dopaminergic medication and STN-DBS restored a normalized
beta modulation proﬁle in patients during fast RAS, possibly reﬂecting
alleviations of Parkinsonian symptoms with movement at faster
rhythms.
4.1. Limitations of the approach
It is conceivable that surgery-related skull defects such as incom-
pletely sealed burr holes may have resulted in a distorted spread of
scalp EEG signals (Litvak et al., 2011; Oostenveld and Oostendorp,
2002). As discussed elsewhere in detail (Gulberti et al., 2015), in our
study we did not observe topographical changes nor local enhance-
ments of signal amplitude, which might be expected to emerge from
skull defects. A further source of concern about perioperative EEG re-
cordings may be related to the “stun” effect, a temporary post-
operative amelioration of parkinsonism due to microlesions as a conse-
quence of electrode implantation (Eusebio and Brown, 2009). Stun ef-
fects are of rather short duration and typically disappear within
1 month after surgery (Jech et al., 2012). In line with these reports,
post-operative UPDRS-III scores in the OFF-DBS condition (assessed
3–5months following surgery in the DOPA off state at time of record-
ings) were not signiﬁcantly different from baseline pre-operative
UPDRS-III scores (respectively 40 ± 10 and 34 ± 12; [t(9) = −
1.66; p = 0.13], paired t-test). In fact, the slightly increased
UPDRS-score argues against residual effects of surgery-related
microlesions. Nevertheless, long-term carry-over effects of chronic
high-frequency DBS may explain the lack of signiﬁcant differences
in the contrasts between the two post-operative conditions (ON ver-
sus OFF-DBS) in the processing of slow and fast RAS. Switching off
the stimulator for 30 min was probably not sufﬁcient to reestablish
the pre-operative pathological oscillation activity. Indeed, at least
3 h OFF-DBS are required to estimate the whole clinical effect of
stimulation (Temperli et al., 2003).
The results of modulation effects of levodopa and DBS on the elec-
trophysiological proﬁle of PD patients could have been partially inﬂu-
enced by the standard procedure applied to test PD patients in the
condition of levodopa withdrawal. For medical and ethical reasons,
medication is usually suspended only during the night before the exper-
imental recordings (for ~12 h). But this period of time is probably too
short to reach a genuine dopa-off state, since the clinical effects of dopa-
mine agonists and dopamine degrading inhibitors, which are frequently
combined with levodopa treatment, are lasting for several days
(Ahlskog et al., 1994; Blin, 2003). Thus, long-term carry-over effects of
anti-parkinsonian medication could not be completely excluded as a
factor possibly inﬂuencing the electrophysiological proﬁle of PD
patients.
Given the temporal proximity of the events in the fast RAS to the os-
cillatory responses, some pre-stimulus oscillatory activity could poten-
tially be also represented in the post-stimulus activity and vice versa.
The local maxima and minima (i.e., the peaks of the power activity)
are not shifted by the time–frequency analysis methods. As evidenced
in Fig. 3A and E, in controls the pre–post-event beta peaks are clearly
separated by a local minima centered around the event, thus minimiz-
ing the probability of temporal smearing between these two separate
components. Moreover, in patients the pre-stimulus beta is absent andthe peak of post-stimulus beta activity is occurring at about 80 ms
after stimulus, thus temporally distinct from pre-stimulus activities.
Additionally, since all conditions and groups were analyzed with the
same time–frequency settings, the signiﬁcant differences between
beta modulations in the different groups or conditions are still reliable,
since equally inﬂuenced by the temporal resolution of time–frequency
analysis applied. In conclusion, from the results of the correlations
between pre- and post-event mean values of beta-band activities we
can exclude carry over effects between pre- and post-event beta-band
activities. In such a case we would have expected signiﬁcant positive
correlations between pre- and post-stimulus beta activities, but this
case was never observed.4.2. Resting-state spectral characteristics
We ﬁrst addressed the question of possible effects of
neuromodulatory interventions on resting-state oscillatory dynam-
ics, particularly focusing on the beta-band. One principal ﬁnding
was an enhancement of absolute power across a broad range of fre-
quencies in patients with PD compared to healthy controls. This
global increase of absolute power in PD patients is in agreement
with previous reports (Moazami-Goudarzi et al., 2008; Tanaka
et al., 2000), which attributed this effect to a pathophysiological
chain reaction initiated by the effects of dopamine denervation on
BG-thalamo-cortical circuitries. In this concept, thalamo-cortical
dysrhythmia (TCD), characterized by a pathological increase of
low-frequency oscillatory bursting in thalamo-cortical modules,
leads to a pathological augmentation of low- and high-frequency ac-
tivities in the EEG (Moazami-Goudarzi et al., 2008).
To the best of our knowledge, the ﬁnding that theta-band power is
increased in patients after DBS surgery is new. Slowing of EEG activity
in comparison to healthy subjects is a consistent ﬁnding in patients
with PD (Soikkeli et al., 1991; Stoffers et al., 2007), and increased
theta power has been associated with clinical measures of disease pro-
gression (Bosboom et al., 2006; Serizawa et al., 2008; Soikkeli et al.,
1991; Stoffers et al., 2007) and cognitive decline, respectively (Neufeld
et al., 1994, 1988; Olde Dubbelink et al., 2013; Sinanović et al., 2005;
Tanaka et al., 2000). It cannot be decidedwith certaintywhether the ob-
served theta increase after DBS surgery was related to progression of
motor symptoms or reduced cognitive functions, as the latter were
not speciﬁcally assessed in this study. However, it is of note that the
mean patient3s postoperative UPDRS-III motor performance OFF-DBS
was only slightly worse compared to preoperative baseline recordings
in DOPA-OFF (40 ± 10 and 34 ± 12, respectively; [t(9) =−1.66; p =
0.13], paired t-test), thus making a general aggravation of motor symp-
toms improbable as a cause for the postoperative theta increase. It is
conceivable that the drastic reduction of chronic, longer lasting
antiparkinsonian medication following surgery (~40% in this patient
sample) may have unmasked some low-frequency components in the
spectral distribution, which were less prominent in the pre-operative
recordings.
Importantly, compared to pre-operative baseline, STN-DBS also led
to a marked reduction of beta- and gamma-power in both absolute
and relative resting-state power spectra. There was no longer a statisti-
cal difference in absolute beta power between PD patients ON-DBS and
controls. Furthermore, ON-DBS was associated with a reduction of beta
power compared to OFF-DBS. Thus, STN-DBS had a strong inﬂuence on
cortical high-frequency activities, particularly in the beta-band. In the
context of the TCD framework, pathological elevations of coactivated
neighboring thalamo-cortical modules at lower frequencies may result
in aberrant high-frequency activity at cortical levels (Llinás et al.,
2005; Moazami-Goudarzi et al., 2008). DBS-induced modulation of in-
hibitory BG output to the thalamus may in turn reduce abnormal
thalamo-cortical rhythmicity and normalize high frequency oscillatory
power in cortical networks (Llinás et al., 2005).
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Auditory–motor coordination may depend upon temporally precise
neuronal interactions across auditory and motor-related brain areas. A
number of recent works have provided evidence for a speciﬁc role of
beta-band modulation in motor timing (Fujioka et al., 2012; Iversen
et al., 2009; Saleh et al., 2010). In PD patients, beta-band activity cannot
bemodulated as fast and efﬁciently as in the healthy brain (Doyle et al.,
2005; Jenkinson and Brown, 2011). Rhythmic auditory stimuli have re-
cently been demonstrated to result in a periodic modulation of beta ac-
tivity within the STN (Joundi et al., 2013). At a cortical level, rhythmic
auditory stimuli (presented in a passive listening task) also activate
motor-related neural networks (Fujioka et al., 2012; Grahn and Brett,
2007; Rao et al., 2001). Fujioka and colleagues observed prominent
beta amplitude modulations within supplementary motor area and in-
ferior frontal gyrus during fast auditory pacing (Fujioka et al., 2012).
Given the intimate anatomical relationships of these two cortical areas
with the STN (Aron and Poldrack, 2006; Haynes and Haber, 2013;
Monakow et al., 1978), it is tempting to speculate that STN-DBS may
speciﬁcally improve cortical beta-band modulation at faster stimulus
rates via modulation of centrofrontal cortical activity. This is in fact
what we observed in our study.
The beta increase that was found to precede stimulus onset in
healthy subjects is consistent with the view of beta-band modulation
playing an important role for timing functions. This distinct pre-
stimulus component, peaking immediately before the expected stimu-
lus onset, was absent in patients with PD, indicating a timekeeping ab-
normality for isochronous sounds. Both the analysis of inter-trial
coherence and the absence of any correlation between pre- and post-
stimulus beta-band ITC values suggest that the broadband response
after the stimulus could be related to an auditory evoked response,
while the pre-stimulus beta-modulation was not phase-locked to the
auditory stimuli, and thus the reported pre-stimulus differences were
due to changes in induced beta-band power. This observation is in line
with the hypothesis that pre-stimulus beta-band activity could reﬂect
an intrinsically generated neuronal modulation, which may serve pre-
dictive functions in rhythm-related tasks (Arnal and Giraud, 2012;
Engel and Fries, 2010; Saleh et al., 2010; Teki, 2014).
While pre-stimulus abnormalities were seen for both slow and fast
RAS, the post-stimulus beta modulation proﬁle of patients with PD
was remarkably unimpaired during slow, but severely impaired during
fast RAS, especially when OFF medication. In controls, stimulus-driven
beta amplitude modulation was temporally precise, irrespective of pac-
ing frequency, starting only after stimulus presentation. During fast au-
ditory pacing, the timing of this post-stimulus-beta amplitude
modulation in patients without dopaminergic therapy became tempo-
rally sluggish and was shifted such that it started ramping already be-
fore stimulus onset. This may contribute to the loss of temporal
alignmentwith external cues presented at high rates observed in PD pa-
tients. Interestingly, an additional evoked component was observed in
the theta frequency range, emerging around 0.2 s post stimulus during
slow RAS, and 0.1 s at fast RAS. Even if this component was not
contained in the time window considered here for the peri-stimulus
analysis, is intriguing to consider it as a pre-stimulus phase-reset for
the next stimulus as described by Giraud and Poeppel (2012) and
Arnal and Giraud (2012).
Before DBS surgery, the stimulus-induced periodic modulations of
broadband neural activity displayed excessively large oscillation ampli-
tudes, reminiscent of exaggerated resonance or decreased suppression
in response to repeating stimuli (Gulberti et al., 2015). Such abnormal
sensory monitoring may hamper the ability of PD patients to respond
appropriately to rhythmic auditory input and partially underlie their
performance deﬁcits during fast auditory pacing. Transferred into a clin-
ical context, impaired entrainment of fast sensory rhythms could also
contribute to the patients3 difﬁculties to synchronize their motor activ-
ity with external cues displayed at high rates (Logigian et al., 1991;Yahalom et al., 2004). Furthermore, defective sensory processing may
partly underlie dysrhythmic motor deﬁcits of PD patients, such as the
so-called “hastening phenomenon”. Instead of precisely synchronizing
with rhythmic external cues, PD patients involuntarily accelerate their
motion. In this condition, impaired sensory processing characterized
by abnormally high oscillation amplitudes could trigger activity along
motor-related cortex-BG loops, decoupling the patient3s motor output
fromhigher ordermotor control areas and entraining it to a pathological
motor rhythmwhichwould then act to involuntarily pacemotor actions
(Freeman et al., 1993; Logigian et al., 1991; Nagasaki et al., 1978).
Interestingly, a more physiological post-stimulus alignment of beta
amplitudemodulationwas restored by levodopa and STN-DBS— specif-
ically for fast auditory pacing — together with a normalization of the
peak size, which was found to be pathologically extended in OFF medi-
cation recordings before DBS surgery. The observed tempo-dependence
of sensitivity to neuromodulatory treatment suggests a speciﬁc role for
distinct cortex-basal ganglia circuitries for rhythm-related processing
during fast auditory pacing. If sensory entrainment has an inﬂuence
on auditory–motor coupling, itmay thus be proposed that dopamine re-
placement therapy and STN-DBS may both improve performance of PD
patients speciﬁcally under conditions of fast auditory pacing.
5. Conclusions
In summary, our results provide evidence for disturbed timekeeping
functions directly linked to altered beta-band activity in PD. In particu-
lar, we provide evidence for a rate-speciﬁc impairment of processing of
fast auditory rhythms in PD patients that is both dopamine-dependent
and sensitive to therapeutic modulation within cortex-basal ganglia
networks. Given the proposed role of beta oscillations for interrelated
processes such as rhythm perception, interval timing and sensorimotor
coordination, an abnormal reactivity of beta-band responses to auditory
stimuli — as in the present study —may contribute to auditory–motor
coupling deﬁcits in patients with PD. Conversely, in light of the normal-
izing effects of levodopa and STN-DBS described here, it is tempting to
suggest that both treatments may allow for a more dynamic conﬁgura-
tion of sensorimotor networks in response to fast RAS, possibly not only
alleviating Parkinsonian impairments of audio–motor synchronization
during fast auditory external pacing, but also affecting information
processes relying on the extraction of predictable temporal cues in
both auditory perception and rhythmic activities (Arnal and Giraud,
2012; Bartolo et al., 2014; Teki, 2014).
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